From the Business/Higher Education Round Table (Australia):
The Seeds of Transition: Initiatives for the 2020 Economy and Beyond
A repositioned economy based on structural change enabling knowledge/IP translation and not restricted by geography is an outcome that will serve Australia well as we move further into the 21st century. And so it is that the contributors for this edition of the B/HERT News bring a focus to initiatives that will be a part of this journey.
B/HERT News #35 [PDF]
Trajan Scientific and Medical’s hemaPEN® microsampling technology has been developed with extensive consultation and evaluation by leading analytical laboratories, clinicians and healthcare professionals.
This month, Trajan presents an exclusive interview with researcher Dr Michele Protti of Pharmaco-Toxicological Analysis, Bologna, Italy, on the future of microsampling and the critical role hemaPEN can play when used in therapeutic drug monitoring for optimal therapy personalization.
Trajan Scientific and Medical’s hemaPEN® has been independently evaluated and the results of the study published in the Royal Society of Chemistry’s journal Analyst - selected for the cover of issue 17. hemaPEN demonstrated significant advantages for blood sampling to support better healthcare decision making.